Table 3.
Population | Outcome indicator | Q1 2019 | Q2 2019 | Q3 2019 | Q4 2019 | Q1 2020 | Q2 2020 | Q3 2020 | Q4 2020 | Total |
Baratric care (n=856) | Reoperation | 105/2 | 129/2 | 90/2 | 130/3 | 85/4 | 54/0 | 171/2 | 77/0 | 841/15 |
98% | 98% | 98% | 98% | 96% | 100% | 99% | 100% | 98% | ||
Deficiency | 83/24 | 96/34 | 64/28 | 89/44 | 59/30 | 39/15 | 127/45 | 61/16 | 618/236 | |
78% | 74% | 70% | 67% | 66% | 72% | 74% | 79% | 72% | ||
Readmission | 105/2 | 129/2 | 90/2 | 128/5 | 88/1 | 54/0 | 167/6 | 76/1 | 837/19 | |
98% | 98% | 98% | 96% | 99% | 100% | 97% | 99% | 98% | ||
Admission time | 102/5 | 125/6 | 87/5 | 130/3 | 86/3 | 52/2 | 162/11 | 74/3 | 818/38 | |
95% | 95% | 95% | 98% | 97% | 96% | 94% | 96% | 96% | ||
Emergency Department (ED) visit | 101/6 | 121/10 | 88/4 | 122/11 | 81/8 | 52/2 | 160/13 | 74/3 | 799/57 | |
94% | 92% | 96% | 92% | 91% | 96% | 92% | 96% | 93% | ||
TWL (total weight loss) | 104/3 | 123/8 | 80/12 | 122/11 | 84/5 | 52/2 | 165/7 | 77/0 | 807/48 | |
97% | 94% | 87% | 92% | 94% | 96% | 96% | 100% | 94% | ||
Survival | 107/0 | 130/1 | 92/0 | 133/0 | 89/0 | 54/0 | 172/1 | 77/0 | 854/2 | |
100% | 99% | 100% | 100% | 100% | 100% | 99% | 100% | 100% | ||
Resulting outcome * 100% | 72/35 | 81/50 | 47/45 | 73/60 | 50/39 | 34/20 | 107/66 | 56/21 | 520/336 | |
67% | 62% | 51% | 55% | 56% | 63% | 62% | 73% | 61% | ||
Bariatric including HRQoL care (n=270) |
Reoperation | 41/2 | 82/0 | 56/1 | 86/2 | - /- | - /- | - /- | - /- | 265/5 |
95% | 100% | 98% | 98% | – | – | – | – | 98% | ||
Deficiency | 32/11 | 64/18 | 41/16 | 60/28 | - /- | - /- | - /- | - /- | 197/73 | |
74% | 78% | 72% | 68% | – | – | – | – | 73% | ||
Readmission | 42/1 | 82/0 | 55/2 | 86/2 | - /- | - /- | - /- | - /- | 265/5 | |
98% | 100% | 96% | 93% | – | – | – | – | 98% | ||
Admission time | 40/3 | 81/1 | 56/1 | 86/2 | - /- | - /- | - /- | - /- | 263/7 | |
93% | 99% | 98% | 98% | – | – | – | – | 97% | ||
ER visit | 42/1 | 76/6 | 53/4 | 82/6 | - /- | - /- | - /- | - /- | 253/17 | |
98% | 93% | 93% | 93% | – | – | – | – | 94% | ||
TWL (total weight loss) | 43/0 | 80/2 | 52/5 | 80/8 | - /- | - /- | - /- | - /- | 255/15 | |
100% | 98% | 91% | 91% | – | – | – | – | 94% | ||
HRQoL | 42/1 | 80/2 | 53/4 | 82/6 | - /- | - /- | - /- | - /- | 257/13 | |
98% | 98% | 93% | 93% | – | – | – | – | 95% | ||
Survival | 43/0 | 82/0 | 57/0 | 88/0 | - /- | - /- | - /- | - /- | 270/0 | |
100% | 100% | 100% | 100% | – | – | – | – | 100% | ||
Resulting outcome * 100% | 29/14 | 56/26 | 31/26 | 48/40 | - /- | - /- | - /- | - /- | 164/106 | |
67% | 68% | 54% | 55% | – | – | – | – | 61% | ||
Breast cancer care (n=663) |
Reoperation | 79/3 | 55/6 | 77/3 | 75/6 | 88/7 | 86/5 | 85/3 | 83/2 | 628/35 |
96% | 90% | 96% | 93% | 93% | 95% | 97% | 98% | 95% | ||
Survival | 82/0 | 60/1 | 80/0 | 81/0 | 94/1 | 90/1 | 87/1 | 85/0 | 659/4 | |
100% | 98% | 100% | 100% | 99% | 99% | 99% | 100% | 99% | ||
Surgical margins | 75/7 | 57/4 | 74/6 | 74/7 | 85/10 | 87/4 | 76/12 | 81/4 | 609/54 | |
91% | 93% | 93% | 91% | 89% | 96% | 86% | 95% | 92% | ||
Recurrance | 82/0 | 61/0 | 80/0 | 81/0 | 95/0 | 91/0 | 87/1 | 85/0 | 662/1 | |
100% | 100% | 100% | 100% | 100% | 100% | 99% | 100% | 100% | ||
Resulting outcome * 100% | 73/9 | 51/10 | 72/8 | 70/11 | 78/17 | 81/10 | 72/16 | 79/6 | 576/87 | |
89% | 84% | 90% | 86% | 82% | 89% | 82% | 93% | 87% |
HRQoL, health-related quality of life.